SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.
| Revenue (Most Recent Fiscal Year) | $167.18M |
| Net Income (Most Recent Fiscal Year) | $-30.91M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.88 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.17 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -12.83% |
| Net Margin (Trailing 12 Months) | -12.83% |
| Return on Equity (Trailing 12 Months) | -14.20% |
| Return on Assets (Trailing 12 Months) | -10.38% |
| Current Ratio (Most Recent Fiscal Quarter) | 8.38 |
| Quick Ratio (Most Recent Fiscal Quarter) | 7.00 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.21 |
| Inventory Turnover (Trailing 12 Months) | 1.30 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.95 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.14 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.75 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.56 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 43.14M |
| Free Float | 41.46M |
| Market Capitalization | $719.16M |
| Average Volume (Last 20 Days) | 0.45M |
| Beta (Past 60 Months) | 0.81 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 98.11% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |